Evaluation reveals combined LiMAx and lactate clearance enhances monitoring of hepatic function in discarded donor livers, implying improved graft viability assessment.
Background. Although lactate clearance provides important information regarding hepatocellular function during normothermic machine perfusion (NMP), the information inferred is adequate to exclude nonfunctioning grafts but is limited in evaluating comprehensive hepatocyte function. Liver maximum capacity (LiMAx), using C 13 -methacetin, has been adopted to assist in the functional assessment of the liver before major oncological resection. We evaluated the combined use of lactate clearance and LiMAx measurement to monitor liver function during extended-duration NMP. Methods. Seven discarded donor livers underwent extended NMP for 87–184 h using a blood-based perfusate and a modified Liver Assist device incorporating hemofiltration. Hepatocellular function was assessed every 6 h using LiMAx: a fixed bolus of C 13 -methacetin was administered and the delta over baseline was measured. Lactate clearance capacity was tested every 24 h by administering 50% sodium lactate to achieve perfusate concentrations of 10–15 mmol/L. Results. Initial lactate clearance to <2.5 mmol/L was achieved within 1.75–7.75 h post-NMP initiation. The median LiMAx value was 829 (range, 325–3130) µg/kg/h. Livers with efficient lactate clearance (<4 h) displayed stable LiMAx profiles with consistently low, flat delta over baseline curves, maintaining similar amplitude for 80 h of perfusion, indicative of preserved hepatocyte function. Conversely, livers with progressive reductions in LiMAx amplitude and curve flattening were associated with deteriorating function and eventual graft failure. Conclusions. LiMAx enables real-time, longitudinal monitoring of hepatocyte metabolic activity during extended NMP. When combined with lactate clearance, it could offer a more comprehensive assessment of graft viability. Incorporating LiMAx into viability criteria could refine current decision-making frameworks for liver transplantation, particularly in marginal grafts.
No takes yet. Share an insight, caveat, or question.
Clarke et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: